Table 1.

Macaque experimental protocol.

Group	Experiment	Macaque	MHC-I haplotype	SIVmac239 iva	ARTb	SeV-Gag/Vif inc	a-SIV IgG ivd
N	Exp 1	NE1	E	Wk 0	Wk 12–32	(−)	(−)
N	Exp 1	NE2	E	Wk 0	Wk 12–32	(−)	(−)
N	Exp 2	NE3	E	Wk 0	Wk 12–32	(−)	Wk 32
N	Exp 1	NW4	W	Wk 0	Wk 12–32	(−)	(−)
N	Exp 2	NW5	W	Wk 0	Wk 12–32	(−)	Wk 32
N	Exp 1	NS6	S	Wk 0	Wk 12–32	(−)	(−)
V	Exp 1	VE1	E	Wk 0	Wk 12–32	Wks 26 and 32	Wk 32
V	Exp 1	VE2	E	Wk 0	Wk 12–32	Wks 26 and 32	Wk 32
V	Exp 2	VE3	E	Wk 0	Wk 12–32	Wks 26 and 32	Wk 32
V	Exp 1	VW4	W	Wk 0	Wk 12–32	Wks 26 and 32	Wk 32
V	Exp 2	VW5	W	Wk 0	Wk 12–32	Wks 26 and 32	Wk 32
V	Exp 1	VS6	S	Wk 0	Wk 12–32	Wks 26 and 32	Wk 32

^aAnimals were intravenously inoculated with SIVmac239.

^bAnimals received ART from week 12 to 32 post-infection.

^cAnimals were intranasally immunized with SeV-Gag and SeV-Vif.

^dAnimals were intravenously administered with anti-SIV IgG.